Characteristics and Costs of NASH Advanced Fibrosis and Cirrhosis in Patients with and without Diabetes Mellitus (DM): Results of a US Real-World Cohort Study

被引：0
|
作者：
Sanyal, Arun J. [1 ]
Bengtson, Lindsay [2 ]
Shreay, Sanatan [3 ]
Kim, W. Ray [4 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Optum, Eden Prairie, MN USA
[3] Gilead Sci, HEOR, Foster City, CA USA
[4] Stanford Univ, Palo Alto, CA 94304 USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2210
引用
收藏
页码：1168A / 1169A
页数：2
相关论文
共 50 条
  • [21] Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada
    Ratzki-Leewing, Alexandria
    Harris, Stewart B.
    Mequanint, Selam
    Reichert, Sonja M.
    Brown, Judith Belle
    Black, Jason Edward
    Ryan, Bridget L.
    BMJ OPEN DIABETES RESEARCH & CARE, 2018, 6 (01)
  • [22] Real-World Demographics and Clinical Characteristics of Type 2 Diabetes Mellitus Patients in Ontario, Canada
    Houlden, Robyn L.
    Golden, Shane
    Shi, Wei Zhe
    Kukaswadia, Atif A.
    Sharma, Arushi
    Quansah, Kobina
    Liu, Aiden R.
    DIABETES, 2022, 71
  • [23] Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
    Buysman, Erin K.
    Chow, Wing
    Henk, Henry J.
    Rupnow, Marcia F. T.
    BMC ENDOCRINE DISORDERS, 2015, 15
  • [24] Characteristics and outcomes of patients with type 2 diabetes mellitus treated with canagliflozin: a real-world analysis
    Erin K. Buysman
    Wing Chow
    Henry J. Henk
    Marcia F. T. Rupnow
    BMC Endocrine Disorders, 15
  • [25] Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
    Huang, Yu-Ting
    Hsieh, Yung-Yu
    Chen, Wei-Ming
    Tung, Shui-Yi
    Wei, Kuo-Liang
    Shen, Chen-Heng
    Chang, Kao-Chi
    Lu, Chung-Kuang
    Yen, Chih-Wei
    Lu, Sheng-Nan
    Hung, Chao-Hung
    Chang, Te-Sheng
    BMC GASTROENTEROLOGY, 2021, 21 (01)
  • [26] Sofosbuvir/velpatasvir is an effective treatment for patients with hepatitis C and advanced fibrosis or cirrhosis in a real-world setting in Taiwan
    Yu-Ting Huang
    Yung-Yu Hsieh
    Wei-Ming Chen
    Shui-Yi Tung
    Kuo-Liang Wei
    Chen-Heng Shen
    Kao-Chi Chang
    Chung-Kuang Lu
    Chih-Wei Yen
    Sheng-Nan Lu
    Chao-Hung Hung
    Te-Sheng Chang
    BMC Gastroenterology, 21
  • [27] The clinical characteristics and prognosis of patients with SAPHO syndrome——a real-world cohort study
    Hongji Duan
    Shuang Gao
    Lihua Zhang
    Le Song
    Jiayu Zhai
    Xiaoli Deng
    Clinical Rheumatology, 2024, 43 : 561 - 568
  • [28] PATIENT CHARACTERISTICS AND SOCIAL DETERMINANTS OF HEALTH IN A LARGE REAL-WORLD COHORT OF VITILIGO PATIENTS IN THE US
    Weiss, S.
    Elyze, M.
    Starzyk, K.
    VALUE IN HEALTH, 2023, 26 (06) : S365 - S365
  • [29] Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real-world multicentre cohort
    Durheim, Michael T.
    Bendstrup, Elisabeth
    Carlson, Lisa
    Sutinen, Eva M.
    Hyldgaard, Charlotte
    Kalafatis, Dimitrios
    Myllarniemi, Marjukka
    Skold, C. Magnus
    Sjaheim, Tone
    RESPIROLOGY, 2021, 26 (10) : 982 - 988
  • [30] CHARACTERISTICS AND CARE PATTERNS OF REAL-WORLD NON-ALCOHOLIC STEATOHEPATITIS (NASH) PATIENTS WITH AND WITHOUT LIVER BIOPSY
    Esposito, Daina
    Titievsky, Lina
    Dui, Simo
    Patel, Yuval
    Wong, Bruce
    Capozza, Thomas
    Ness, Erik
    Gallagher, Kerrin
    Jamal-Allial, Aziza
    Nguyen, Mindie H.
    HEPATOLOGY, 2020, 72 : 959 - 960
12345